Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss.

The Dobbs decision was associated with a moderate but significant relative reduction in OB/GYN practitioners in states that adopted restrictive abortion laws compared with states that enacted abortion ...

The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, ...

Aside from a nice pick-me-up researchers say that a cup of joe could be good for you too…if you stick to the right amount.

Researchers have found in a new study that elevated triglyceride-glucose (TyG) index, a marker of insulin resistance, was ...

Continuous glucose monitors don’t just help people with diabetes maintain healthy blood sugar levels, a new study sa ...

We spoke to five people about their weight loss and the very different health problems that caused it, while experts explain what to look ...

Management to Hold Investor Day Conference Call Today at 10:00am ET Reported record product revenue of $11.6 million in Q4 2024, an increase of 59% over Q4 2023, representing the 16th straight quarter ...

The global burden of diabetic nephropathy increased from 1990 to 2021, and is projected to continue increasing to 2050, ...

Dubai Health organised the second edition of 'Clinic of Hope' initiative at Al Jalila Children's Hospital, providing essential free medical care to 300 children in need across more than 20 specialised ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

The treatment was approved by China’s National Medical Products Administration (NMPA) and is China's first, and the world’s second, approved IGF-1R antibody drug.